pocketful logo light
pocketful logo light
Nexus Surgical and Medicare Ltd logo

Nexus Surgical and Medicare Ltd

NSE: BSE: 538874

20.49

(2.40%)

Mon, 25 May 2026, 04:54 pm

Nexus Surgical and Medicare Share Price Live Chart

1 Day

(2.40%)

No Result Found

Summary

  • Market Cap

    12.58

  • Net Profit

    0.50

  • P/B

    8.50

  • Sector P/E

    80.92

  • P/E

    18.12

  • EV/EBITDA

    12.78

  • Debt/Equity (Industry)

    0.52

  • Interest Cover (Industry)

    0

  • ROCE (Industry)

    0

  • RONW (Industry)

    0

  • ROE

    9.14

  • ROCE

    12.43

  • Debt/Equity

    0

  • EPS (TTM)

    1.07

  • Dividend Yield

    0

  • Book Value

    2.54

  • Interest Cover

    68

Analysis

all

thumbs up icon

Pros

  • Nexus Commodities and Technologies has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 9.6% each year.
  • Nexus Commodities and Technologies has sufficient cash runway for more than 3 years based on current free cash flow.
  • Debt is covered by short term assets, assets are 2.1x debt.
  • Nexus Commodities and Technologies has no long term commitments.
  • Nexus Commodities and Technologies's level of debt (5.2%) compared to net worth is satisfactory (less than 40%).
thumbs up icon

Cons

  • Unable to evaluate Nexus Commodities and Technologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Nexus Commodities and Technologies's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Nexus Commodities and Technologies's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Operating cash flow is negative therefore debt is not well covered.
  • High level of physical assets or inventory.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters18.7318.7318.7318.7318.73
FII00000
DII00000
Public81.2781.2781.2781.2781.27
Government00000

Read More

Technical Analysis

RSI

51.61

MACD

0.49

50 DMA

19.26

200 DMA

17.72

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic28.5224.0722.2419.6217.7915.1710.72
Fibonacci24.0722.3721.3219.6217.9216.8715.17
Camarilla21.6221.2220.8119.6219.9919.5819.18

Pivots Level: Classic

R3

+8.90

28.52

R2

+4.45

24.07

R1

+2.61

22.24

19.62
19.62
Pivot Point
LTP: 21.01

S1

-1.84

17.79

S2

-4.45

15.17

S3

-8.90

10.72

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    21.11

  • 20-EMA

    20.84

  • 30-EMA

    20.44

  • 50-EMA

    19.76

  • 100-EMA

    18.79

  • 200-EMA

    18.08

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
14 Feb 2026board-meetingsQuarterly Results
14 Nov 2025board-meetingsQuarterly Results
01 Sept 2025agm
25 Jul 2024agm
11 Aug 2023agm
01 Sept 2022agm
02 Sept 2021agm

Read More

Peer Comparison

Nexus Surgical and Medicare Ltd logo

Nexus Surgical and Medicare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Read More

Nexus Surgical and Medicare Ltd About

Nexus Surgical & Medicare is engaged into trading of medical essentials.

Industry

Trading

Founded

1992

Headquarters

CEO

Employees

Contact

Website icon

Website

http://www.nexusmed.co.in

Email icon

Email

nexuscomm92@gmail.com

Phone icon

Phone

Location icon

Location

Gala No 4 Saarthak Bldg No 1, Square Industrial Park, Palghar, Maharashtra, 401208

Read More

Nexus Surgical and Medicare Ltd Company History

YearHistory
1992
  • Nexus Commodities and Technologies Limited was incorporated as a public limited company under the Companies Act, 1956.
2020
  • The company name was changed to Nexus Surgical and Medicare Ltd. from Nexus Commodities and Technologies Ltd.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
ACQUITOR FINANCIAL SERVICES PVT.LTD.bulkBuy437262022 May 2026
RUCHEE CHOTRAbulkSell447012022 May 2026
MANOJ KUMARbulkSell3967519.0520 May 2026
ACQUITOR FINANCIAL SERVICES PVT.LTD.bulkBuy4009119.0520 May 2026
RUCHEE CHOTRAbulkSell352991918 May 2026
RISHABH NEGIbulkBuy354241918 May 2026
LAXMAN SOPAN WAGHMODEbulkSell5555516.0725 Sept 2025
RAJEEV KUMAR SINGHbulkSell4258314.8530 Jan 2025
ACQUITOR FINANCIAL SERVICES PVT.LTD.bulkBuy3500014.7230 Jan 2025
HARIVARDHAN STEEL & ALLOYS PRIVATE LIMTEDbulkBuy3493119.0227 Nov 2024

Read More

Nexus Surgical and Medicare Ltd News

Nexus Surgical board meet on May 28

Nexus Surgical and Medicare Limited will hold a board meeting on May 28, 2026, to consider audited financial results for FY26.

22 May 2026

companies

Nexus Surgical Submits Q4 FY26 SEBI Certificate

Nexus Surgical And Medicare Limited submitted its quarterly certificate under SEBI Depositories Regulations for Q4 FY26, confirming no share dematerialisation activity during the quarter.

08 Apr 2026

companies

Nexus Surgical Reports 49.76% Jump in Q3 Profit

Nexus Surgical and Medicare Limited posted Q3 FY26 net profit of ₹17.01 lakhs, up 49.76% YoY. Sales surged 97.55% to ₹293.08 lakhs with nine-month profit rising 21.29% to ₹49.62 lakhs.

14 Feb 2026

co actions results

Nexus Surgical Clarifies Price Movement to BSE

Nexus Surgical & Medicare responds to BSE surveillance query, attributing recent stock price movements to market conditions while confirming regulatory compliance and no undisclosed information.

03 Jan 2026

stocks

Nexus Surgical and Medicare Reports Quarterly Financial Results for September 2025

Nexus Surgical and Medicare Limited reported unaudited quarterly financial results for the quarter and half year ended September 30, 2025, showing total income of Rs. 99.49 lakh for the quarter with profit after tax of Rs. 32.61 lakh. The company's board approved these results on November 14, 2025, with basic and diluted earnings per share of Rs. 0.60 for the quarter.

14 Nov 2025

earnings

Read More